PharmaGraphX

Log in Get Started

Repaglinide

Prandin

Uncategorized

Standard

Half-life

1 hour

Protein Binding

98%

Metabolized By

N/A

External

Drugs.com

Mechanism of action

Closes KATP channels on pancreatic beta cells, stimulating rapid insulin release

Recorded indications

From the drug index — may include conditions studied rather than approved indications

·Advanced Malignancies
·Healthy
·Obesity &Amp; Overweight
·TP53 Y220C Mutation
·Advanced Solid Tumors

Interactions

No curated interaction pairs are recorded for Repaglinide. This is not a statement that none exist — check a full interaction reference before combining.

Common adverse effects

Hypoglycemia
Weight gain
Upper respiratory infection

Food, alcohol & herbal

Food

Take 1-30 minutes before meals

Alcohol · major

Severe hypoglycemia risk

Pharmacokinetics

Half-life: 1 hour
Protein binding: 98%
Metabolised by: CYP2C8, CYP3A4

Pregnancy & lactation

Not recorded for Repaglinide. Absence here means this database does not hold a category — not that the drug is safe in pregnancy or breastfeeding.

Sources

Assembled from: drug index, curated drug database.

Not a substitute for clinical judgement